Skip to main content
. 2020 Jun 3;3(6):e207445. doi: 10.1001/jamanetworkopen.2020.7445

Figure 2. Percentage of Qualified Health Plans That Required Prior Authorization for HIV Pre-exposure Prophylaxis by Rating Area in 2019.

Figure 2.

The rate of prior authorization requirement for combined tenofovir disoproxil fumarate and emtricitabine by unique Affordable Care Act–compliant plans offered in the individual Affordable Care Act Marketplace during 2019 was mapped by rating area.